HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study.

AbstractBackground:
Numerous studies have reported associations between the brain-derived neurotrophic factor (BDNF) gene and psychiatric disorders, including suicidal behavior, although with conflicting results.
Methods:
A total of 250 major depressive disorder patients were collected in the context of a European multicenter resistant depression study and treated with antidepressants at adequate doses for at least 4 weeks. Suicidality was assessed using the Mini International Neuropsychiatric Interview and Hamilton Rating Scale for Depression, and treatment response using the HAM-D. Genotyping was performed for the functional Val66Met polymorphism (rs6265) and 7 additional tagging single nucleotide polymorphisms within the BDNF gene.
Results:
Neither BDNF single markers nor haplotypes were found to be associated with suicide risk and lifetime history of suicide attempts. Gender-specific analyses revealed nonsignificant single marker (rs908867) and haplotypic association with suicide risk in males after multiple testing correction. Analyzing treatment response phenotypes, the functional Val66Met polymorphism as well as rs10501087 showed significant genotypic and haplotypic association with suicide risk in remitters (n=34, 13.6%).
Conclusions:
Considering the sample size, the present findings need to be replicated in larger samples to confirm or refute a role of BDNF in the investigated suicidal behavior phenotypes.
AuthorsAlexandra Schosser, Laura Carlberg, Raffaella Calati, Alessandro Serretti, Isabel Massat, Christoph Spindelegger, Sylvie Linotte, Julien Mendlewicz, Daniel Souery, Joseph Zohar, Stuart Montgomery, Siegfried Kasper
JournalThe international journal of neuropsychopharmacology (Int J Neuropsychopharmacol) Vol. 20 Issue 10 Pg. 782-787 (10 01 2017) ISSN: 1469-5111 [Electronic] England
PMID28977521 (Publication Type: Journal Article, Multicenter Study)
Copyright© The Author 2017. Published by Oxford University Press on behalf of CINP.
Chemical References
  • Antidepressive Agents
  • Brain-Derived Neurotrophic Factor
  • BDNF protein, human
Topics
  • Antidepressive Agents (therapeutic use)
  • Brain-Derived Neurotrophic Factor (genetics)
  • Depressive Disorder, Major (drug therapy, genetics)
  • Depressive Disorder, Treatment-Resistant (drug therapy, genetics)
  • Europe
  • Female
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genotyping Techniques
  • Haplotypes
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Psychiatric Status Rating Scales
  • Sex Factors
  • Suicide
  • White People

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: